ALPHA9 ONCOLOGY Trademark
Trademark Overview
On Friday, November 22, 2024, a trademark application was filed for ALPHA9 ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the ALPHA9 ONCOLOGY trademark a serial number of 98867926. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, July 28, 2025. This trademark is owned by Alpha-9 Oncology Inc.. The ALPHA9 ONCOLOGY trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceuticals and preparations, namely, radiodiagnostics and radiotherapeutics and their preparations, for the diagnosis and treatment of cancer
Medical services in the field of nuclear medicine and medical imaging and treatment of cancer by use of targeted delivery of a radionuclide
Development of medical products in the field of nuclear medicine
General Information
| Serial Number | 98867926 |
| Word Mark | ALPHA9 ONCOLOGY |
| Filing Date | Friday, November 22, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Monday, July 28, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the stylized word 'ALPHA' followed by the number '9'; all above the word 'ONCOLOGY'. |
| Goods and Services | Pharmaceuticals and preparations, namely, radiodiagnostics and radiotherapeutics and their preparations, for the diagnosis and treatment of cancer |
| Pseudo Mark | ALPHA NINE ONCOLOGY |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Medical services in the field of nuclear medicine and medical imaging and treatment of cancer by use of targeted delivery of a radionuclide |
| NOT AVAILABLE | ONCOLOGY |
| Goods and Services | Development of medical products in the field of nuclear medicine |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 22, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 28, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 22, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Alpha-9 Oncology Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Vancouver, British Columbia V5T1M4
CA |
Trademark Events
| Event Date | Event Description |
| Friday, November 22, 2024 | NEW APPLICATION ENTERED |
| Monday, May 12, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 15, 2025 | ASSIGNED TO EXAMINER |
| Friday, May 30, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 30, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, July 28, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 28, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 28, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, May 30, 2025 | NON-FINAL ACTION E-MAILED |
